Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The anti-inflammatory activity of clarithromycin inhibits TNFalpha production and prolongs survival following lipopolysaccharide administration in mice.
Tkalcević VI, Bosnjak B, Pasalić I, Hrvacić B, Situm K, Kramarić MD, Glojnarić I, Eraković Haber V. Tkalcević VI, et al. Among authors: glojnaric i. Int J Antimicrob Agents. 2008 Aug;32(2):195-6. doi: 10.1016/j.ijantimicag.2008.03.016. Epub 2008 Jun 20. Int J Antimicrob Agents. 2008. PMID: 18571382 No abstract available.
Azithromycin inhibits macrophage interleukin-1β production through inhibition of activator protein-1 in lipopolysaccharide-induced murine pulmonary neutrophilia.
Bosnar M, Čužić S, Bošnjak B, Nujić K, Ergović G, Marjanović N, Pašalić I, Hrvačić B, Polančec D, Glojnarić I, Eraković Haber V. Bosnar M, et al. Among authors: glojnaric i. Int Immunopharmacol. 2011 Apr;11(4):424-34. doi: 10.1016/j.intimp.2010.12.010. Epub 2010 Dec 30. Int Immunopharmacol. 2011. PMID: 21195124
Azithromycin and clarithromycin inhibit lipopolysaccharide-induced murine pulmonary neutrophilia mainly through effects on macrophage-derived granulocyte-macrophage colony-stimulating factor and interleukin-1beta.
Bosnar M, Bosnjak B, Cuzic S, Hrvacic B, Marjanovic N, Glojnaric I, Culic O, Parnham MJ, Erakovic Haber V. Bosnar M, et al. Among authors: glojnaric i. J Pharmacol Exp Ther. 2009 Oct;331(1):104-13. doi: 10.1124/jpet.109.155838. Epub 2009 Jul 24. J Pharmacol Exp Ther. 2009. PMID: 19633061
N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.
Bosnar M, Kragol G, Koštrun S, Vujasinović I, Bošnjak B, Bencetić Mihaljević V, Marušić Ištuk Z, Kapić S, Hrvačić B, Brajša K, Tavčar B, Jelić D, Glojnarić I, Verbanac D, Culić O, Padovan J, Alihodžić S, Eraković Haber V, Spaventi R. Bosnar M, et al. Among authors: glojnaric i. J Med Chem. 2012 Jul 12;55(13):6111-23. doi: 10.1021/jm300356u. Epub 2012 Jun 25. J Med Chem. 2012. PMID: 22697905
Macrolactonolides: a novel class of anti-inflammatory compounds.
Tomašković L, Komac M, Makaruha Stegić O, Munić V, Ralić J, Stanić B, Banjanac M, Marković S, Hrvačić B, Čipčić Paljetak H, Padovan J, Glojnarić I, Eraković Haber V, Mesić M, Merćep M. Tomašković L, et al. Among authors: glojnaric i. Bioorg Med Chem. 2013 Jan 1;21(1):321-32. doi: 10.1016/j.bmc.2012.10.036. Epub 2012 Oct 30. Bioorg Med Chem. 2013. PMID: 23199485
29 results